Suchergebnisse - Rotshteyn, Yakov

Pharmacokinetic and pharmacodynamic profile following oral administration of the phosphodiesterase (PDE)4 inhibitor V11294A in healthy volunteers von Gale, Donna Donigi, Landells, Linda J, Spina, Domenico, Miller, Alan J, Smith, Kate, Nichols, Terry, Rotshteyn, Yakov, Tonelli, Alfred, Lacouture, Peter, Burch, Ronald M, Page, Clive P, O'Connor, Brian J

Volltext Volltext Volltext

Anti-HIV-1 Activity of Weekly or Biweekly Treatment with Subcutaneous PRO 140, a CCR5 Monoclonal Antibody von Jacobson, Jeffrey M., Thompson, Melanie A., Lalezari, Jacob P., Saag, Michael S., Zingman, Barry S., D’Ambrosio, Paul, Stambler, Nancy, Rotshteyn, Yakov, Marozsan, Andre J., Maddon, Paul J., Morris, Stephen A., Olson, William C.

Volltext Volltext Volltext

Novel Small-Molecule Inhibitors of Hepatitis C Virus Entry Block Viral Spread and Promote Viral Clearance in Cell Culture von Coburn, Glen A., Fisch, Danielle N., Moorji, Sameer M., de Muys, Jean-Marc, Murga, Jose D., Paul, Dorothy, Provoncha, Kathleen P., Rotshteyn, Yakov, Han, Amy Q., Qian, Dapeng, Maddon, Paul J., Olson, William C.

Volltext Volltext Volltext

Phase 2a Study of the CCR5 Monoclonal Antibody PRO 140 Administered Intravenously to HIV-Infected Adults von Jacobson, Jeffrey M., Lalezari, Jacob P., Thompson, Melanie A., Fichtenbaum, Carl J., Saag, Michael S., Zingman, Barry S., D'Ambrosio, Paul, Stambler, Nancy, Rotshteyn, Yakov, Marozsan, Andre J., Maddon, Paul J., Morris, Stephen A., Olson, William C.

Volltext Volltext Volltext